Insights from ESMO Breast 2024 Annual Meeting
Video Player is loading.
10 seconds
Playback speed
FeDeriCa Trial Final Analysis: Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection + Chemo in HER2+ eBC
Comments 0
Login to view comments.
Click here to Login
